Mutation in NLGN1 was relatively rare with a prevalence of only 1.6% in CRC samples (Fig. 6D), and mutation was not associated with NLGN1 mRNA expression (Fig. 6B). This evidence concerns the gene NLGN1 and colorectal carcinoma.